Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition.
Catalano A, Adlesic M, Kaltenbacher T, Klar RFU, Albers J, Seidel P, Brandt LP, Hejhal T, Busenhart P, Röhner N, Zodel K, Fritsch K, Wild PJ, Duyster J, Fritsch R, Brummer T, Frew IJ. Catalano A, et al. Among authors: busenhart p. Cancers (Basel). 2021 Apr 13;13(8):1852. doi: 10.3390/cancers13081852. Cancers (Basel). 2021. PMID: 33924486 Free PMC article.
A versatile modular vector system for rapid combinatorial mammalian genetics.
Albers J, Danzer C, Rechsteiner M, Lehmann H, Brandt LP, Hejhal T, Catalano A, Busenhart P, Gonçalves AF, Brandt S, Bode PK, Bode-Lesniewska B, Wild PJ, Frew IJ. Albers J, et al. Among authors: busenhart p. J Clin Invest. 2015 Apr;125(4):1603-19. doi: 10.1172/JCI79743. Epub 2015 Mar 9. J Clin Invest. 2015. PMID: 25751063 Free PMC article.
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors.
Montalban-Arques A, Katkeviciute E, Busenhart P, Bircher A, Wirbel J, Zeller G, Morsy Y, Borsig L, Glaus Garzon JF, Müller A, Arnold IC, Artola-Boran M, Krauthammer M, Sintsova A, Zamboni N, Leventhal GE, Berchtold L, de Wouters T, Rogler G, Baebler K, Schwarzfischer M, Hering L, Olivares-Rivas I, Atrott K, Gottier C, Lang S, Boyman O, Fritsch R, Manz MG, Spalinger MR, Scharl M. Montalban-Arques A, et al. Among authors: busenhart p. Cell Host Microbe. 2021 Oct 13;29(10):1573-1588.e7. doi: 10.1016/j.chom.2021.08.001. Epub 2021 Aug 27. Cell Host Microbe. 2021. PMID: 34453895 Free article.
β6 -integrin serves as a novel serum tumor marker for colorectal carcinoma.
Bengs S, Becker E, Busenhart P, Spalinger MR, Raselli T, Kasper S, Lang S, Atrott K, Mamie C, Vavricka SR, von Boehmer L, Knuth A, Tuomisto A, Mäkinen MJ, Hruz P, Turina M, Rickenbacher A, Petrowsky H, Weber A, Frei P, Halama M, Jenkins G, Sheppard D, Croner RS, Christoph J, Britzen-Laurent N, Naschberger E, Schellerer V, Stürzl M, Fried M, Rogler G, Scharl M. Bengs S, et al. Among authors: busenhart p. Int J Cancer. 2019 Aug 1;145(3):678-685. doi: 10.1002/ijc.32137. Epub 2019 Jan 29. Int J Cancer. 2019. PMID: 30653264
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer.
Busenhart P, Montalban-Arques A, Katkeviciute E, Morsy Y, Van Passen C, Hering L, Atrott K, Lang S, Garzon JFG, Naschberger E, Hartmann A, Rogler G, Stürzl M, Spalinger MR, Scharl M. Busenhart P, et al. J Immunother Cancer. 2022 Feb;10(2):e003465. doi: 10.1136/jitc-2021-003465. J Immunother Cancer. 2022. PMID: 35131862 Free PMC article.
A Novel OGR1 (GPR68) Inhibitor Attenuates Inflammation in Murine Models of Colitis.
de Vallière C, Bäbler K, Busenhart P, Schwarzfischer M, Maeyashiki C, Schuler C, Atrott K, Lang S, Spalinger MR, Scharl M, Ruiz-Castro PA, Hausmann M, Rogler G. de Vallière C, et al. Among authors: busenhart p. Inflamm Intest Dis. 2021 Jul 19;6(3):140-153. doi: 10.1159/000517474. eCollection 2021 Sep. Inflamm Intest Dis. 2021. PMID: 34722644 Free PMC article.
Protein Tyrosine Phosphatase Non-Receptor Type 2 Function in Dendritic Cells Is Crucial to Maintain Tissue Tolerance.
Hering L, Katkeviciute E, Schwarzfischer M, Busenhart P, Gottier C, Mrdjen D, Komuczki J, Wawrzyniak M, Lang S, Atrott K, Becher B, Rogler G, Scharl M, Spalinger MR. Hering L, et al. Among authors: busenhart p. Front Immunol. 2020 Aug 18;11:1856. doi: 10.3389/fimmu.2020.01856. eCollection 2020. Front Immunol. 2020. PMID: 32973765 Free PMC article.
Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.
Katkeviciute E, Hering L, Montalban-Arques A, Busenhart P, Schwarzfischer M, Manzini R, Conde J, Atrott K, Lang S, Rogler G, Naschberger E, Schellerer VS, Stürzl M, Rickenbacher A, Turina M, Weber A, Leibl S, Leventhal GE, Levesque M, Boyman O, Scharl M, Spalinger MR. Katkeviciute E, et al. Among authors: busenhart p. J Clin Invest. 2021 Jan 4;131(1):e140281. doi: 10.1172/JCI140281. J Clin Invest. 2021. PMID: 33001862 Free PMC article.
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma.
Weisberg E, Chowdhury B, Meng C, Case AE, Ni W, Garg S, Sattler M, Azab AK, Sun J, Muz B, Sanchez D, Toure A, Stone RM, Galinsky I, Winer E, Gleim S, Gkountela S, Kedves A, Harrington E, Abrams T, Zoller T, Vaupel A, Manley P, Faller M, Chung B, Chen X, Busenhart P, Stephan C, Calkins K, Bonenfant D, Thoma CR, Forrester W, Griffin JD. Weisberg E, et al. Among authors: busenhart p. Blood Cancer J. 2022 Jul 19;12(7):110. doi: 10.1038/s41408-022-00704-7. Blood Cancer J. 2022. PMID: 35853853 Free PMC article.